Premium
New evidence from the Prostate Cancer Prevention Trial may exculpate cyclooxygenase ( COX ) blockers in erectile dysfunction
Author(s) -
Cole Alexander P.,
Leow Jeffrey J.,
Trinh QuocDien
Publication year - 2016
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.13343
Subject(s) - medicine , erectile dysfunction , rofecoxib , prostate cancer , heart failure , heart disease , disease , prostacyclin , cyclooxygenase , cancer , biochemistry , chemistry , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom